Description
- Risk assessments using real data confirm that the chronic risk assessment for adults is the key driver of honey bee risk according to the EFSA Bee GD as stated in the original impact analysis
- A more discriminating risk assessment can be achieved by applying the standard EPPO 2010 approach based on the use of NOEDD endpoints and more realistic exposure assumptions
- The EFSA 2013 approach can be significantly improved by taking into account the type of endpoint (NOEDD or LDD5) and the dose-response relationship
to more accurately meet the proposed protection goal - Using HB endpoints for BB and SB screening and tier 1 RA will let to failed BB and SB chronic RA for almost all compounds and their products, as valid
laboratory methods will not be available in the next future - Industry is committed to pursue dialog with regulatory authorities and EFSA to share our experience and data to help develop a workable way forward